GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Canntab Therapeutics Ltd (FRA:TBF1) » Definitions » 6-Month Price Index

Canntab Therapeutics (FRA:TBF1) 6-Month Price Index : 1.00 (As of Nov. 09, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Canntab Therapeutics 6-Month Price Index?

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2024-11-09), Canntab Therapeutics's 6-Month Price Index is 1.00.


Competitive Comparison of Canntab Therapeutics's 6-Month Price Index

For the Drug Manufacturers - Specialty & Generic subindustry, Canntab Therapeutics's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Canntab Therapeutics  (FRA:TBF1) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Canntab Therapeutics  (FRA:TBF1) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.


Canntab Therapeutics 6-Month Price Index Related Terms

Thank you for viewing the detailed overview of Canntab Therapeutics's 6-Month Price Index provided by GuruFocus.com. Please click on the following links to see related term pages.


Canntab Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
1 Adelaide Street East, Suite 801, Toronto, ON, CAN, M5C 2V9
Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use.

Canntab Therapeutics Headlines

No Headlines